2023 ACI: A Focus on Emergency Physicians

Presentation slides and video from the 2023 Advances in Cancer Immunotherapy^™ Series: A Focus on Emergency Physicians were presented virtually on June 28, 2023.

Program Organizers

• Paul Jansson, MD, MS – Brigham and Women's Hospital, Harvard Medical School
• Alexa Meara, MD, MS – The Ohio State University James Cancer Center

Program Faculty

• Jason Bischof, MD, FACEP – The Ohio State University Wexner Medical Center

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Program Learning Objectives

• Describe the basic principles of cancer immunotherapy.

• Describe the mechanisms of immune-related adverse reactions from cancer immunotherapy treatment.

• Identify and properly triage immune-related adverse events related to cancer immunotherapy.

You can view the program agenda here.

Please note on-demand recordings are not available for continuing education credits.